ATC Group: C09DA01 Losartan and diuretics

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C09DA01 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C09 Agents acting on the renin-angiotensin system
3 C09D Angiotensin II antagonists, combinations
4 C09DA Angiotensin II antagonists and diuretics
5 C09DA01 Losartan and diuretics

Related product monographs

Title Information Source Document Type  
FORTZAAR Tablet Health Products Regulatory Authority (ZA) MPI, Generic
HYZAAR Film-coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
LOSARB PLUS Film-coated tablet MPI, EU: PIL

Medicines in this ATC group

United States (US)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.